Cargando…
Simvastatin Induces Delayed Apoptosis Through Disruption of Glycolysis and Mitochondrial Impairment in Neuroblastoma Cells
Simvastatin, a commonly used cholesterol‐lowering drug, inhibits the mevalonate pathway involved in the synthesis of the mitochondrial electron carrier coenzyme Q10 (CoQ10), as well as other bioenergetics substrates. The purpose of this study was to investigate simvastatin exposure on mitochondrial...
Autores principales: | Kuzyk, Crystal L., Anderson, Colin C., Roede, James R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214657/ https://www.ncbi.nlm.nih.gov/pubmed/31917509 http://dx.doi.org/10.1111/cts.12740 |
Ejemplares similares
-
Time-dependent simvastatin administration enhances doxorubicin toxicity in neuroblastoma
por: Anderson, Colin C., et al.
Publicado: (2020) -
Inhibition of glycolysis and mitochondrial respiration promotes radiosensitisation of neuroblastoma and glioma cells
por: Nile, Donna L., et al.
Publicado: (2021) -
Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts
por: Teixeira, Lívia, et al.
Publicado: (2022) -
Simvastatin Induces Apoptosis of Fibroblast-Like Synoviocytes
por: Litinsky, Ira, et al.
Publicado: (2009) -
Identification of Neuroblastoma Subgroups Based on Three-Dimensional Telomere Organization()()
por: Kuzyk, Alexandra, et al.
Publicado: (2016)